Skip to main content
NANJING RED SUN CO., LTD logo

NANJING RED SUN CO., LTD — Investor Relations & Filings

Ticker · 000525 ISIN · CNE0000002Z5 LEI · 655600608JEK9VURCH82 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,221 across all filing types
Latest filing 2023-05-30 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 000525

About NANJING RED SUN CO., LTD

https://www.chinaredsun.com

Nanjing Red Sun Co., Ltd. specializes in the research, development, manufacturing, and distribution of agrochemicals and fine chemicals. The company maintains a vertically integrated industrial chain that encompasses the production of basic chemical raw materials, intermediates, and finished formulations. Its core product portfolio includes a diverse range of herbicides, insecticides, and fungicides, with a focus on high-efficiency solutions such as diquat and various pyridine-based chemicals. Red Sun emphasizes technological innovation and green manufacturing to support sustainable agricultural practices. By leveraging large-scale production capacities and advanced biochemical research, the company provides comprehensive crop protection solutions to a global customer base.

Recent filings

Filing Released Lang Actions
关于延期回复深圳证券交易所年报问询函的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (789 characters) regarding the company's request for an extension to reply to an inquiry letter from the Shenzhen Stock Exchange about the 2022 annual report. It does not contain the annual report itself or detailed financial data, but rather a regulatory communication about the timing of a response to a regulatory inquiry. The document states it is an announcement and does not include substantive financial statements or management discussion. Therefore, it fits best as a Regulatory Filing (RNS) rather than an Annual Report (10-K) or Report Publication Announcement (RPA).
2023-05-30 Chinese
关于股票交易异常波动暨风险提示的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding abnormal stock price fluctuations and risk warnings related to the company. It includes explanations about stock price movements, legal proceedings related to pre-restructuring, risk factors, and regulatory investigations. It does not contain financial statements or detailed financial data. The document is a regulatory announcement informing investors about stock trading risks and company status, not a financial report or earnings release. It fits best under Regulatory Filings (RNS) as it is a compliance and risk disclosure announcement without substantive financial data or report content.
2023-05-24 Chinese
关于股票交易异常波动暨风险提示的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement by the company regarding abnormal stock price fluctuations and associated risk disclosures. It references recent financial reports (2022 Annual Report and 2023 Q1 Report) but does not contain any financial statements or detailed financial data itself. The document mainly provides explanations, risk warnings, and updates on legal and restructuring matters affecting the company. It is relatively short (2558 characters) and serves as a regulatory disclosure about stock trading anomalies and risk factors rather than a full financial report or earnings release. Therefore, it fits best into the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance disclosures that do not fit other specific categories.
2023-05-21 Chinese
关于收到南京中院《民事裁定书》的公告
Legal Proceedings Report Classification · 95% confidence The document is a public announcement by 南京红太阳股份有限公司 regarding the receipt of a civil ruling (民事裁定书) from the Nanjing Intermediate People's Court. It details the court's decision to reject a review application related to the substantive merger reorganization of several companies including the company's controlling shareholder. The document discusses legal proceedings, court rulings, and the impact on the company, but does not contain financial statements, earnings data, or management discussion of financial results. It is primarily a legal update and risk disclosure related to ongoing restructuring and court decisions. The document length is 2670 characters, which is relatively short and focused on legal matters. Therefore, it fits best under Legal Proceedings Report (LTR) rather than a financial report or announcement of a report publication.
2023-05-16 Chinese
关于股票交易异常波动暨风险提示的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from the company regarding abnormal stock price fluctuations and risk warnings. It references recent financial reports (2022 Annual Report and 2023 Q1 Report) but does not contain any financial statements or detailed financial data itself. The document mainly provides explanations about stock price movements, legal proceedings related to pre-restructuring, regulatory investigations, and risk disclosures. It is a regulatory announcement aimed at informing investors about stock trading risks and company status rather than a financial report or earnings release. The document length is short (1940 characters), and it serves as a formal disclosure to comply with stock exchange rules. Therefore, it fits best under Regulatory Filings (RNS).
2023-05-10 Chinese
关于公司预重整事项的进展公告
Regulatory Filings Classification · 95% confidence The document is a progress announcement regarding the company's pre-restructuring (pre-reorganization) status, issued by the company and referencing court decisions and ongoing procedures. It is a regulatory update about the company's financial distress and potential restructuring, including risk warnings about possible delisting. The document is relatively short (1701 characters) and serves as a status update rather than a full financial report or audit. It does not contain financial statements or detailed financial analysis. It is not an annual or interim report, nor an earnings release. It is not a call transcript or management report. It is a regulatory announcement about a significant legal and financial event affecting the company. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-05-08 Chinese

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.